NIH researchers uncovered new details on rare immune disease
On May 3, 2023, National Institutes of Health (NIH) scientists announced that they had uncovered new details on…
On May 3, 2023, National Institutes of Health (NIH) scientists announced that they had uncovered new details on…
On Apr. 17, 2023, the U.S. FDA approved Gamida Cell’s Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord…
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
On Mar. 27. 2023, Thermo Fisher Scientific and the University of California, San Francisco, announced they will accelerate…
On Mar. 23, 2023, the Fred Hutchinson Cancer Center (FHCRC) announced a new building in South Lake Union…
On Mar. 13, 2023, Pfizer announced an agreement to acquire Seagen, a global biotechnology company that discovers, develops…
On Mar. 7, 2023, researchers at the National Institutes of Health reported the benefits of screening adult patients…
On Feb. 21, 2023, Gilead Sciences announced positive data from three retrospective real-world studies which demonstrated that initiation…
On Feb. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a major step forward…
On Jan. 13, 2023, a team of researchers including faculty at the Translational Genomics Research Institute (TGen), part…
On Jan. 6, 2023, the Purdue Center for Cancer Research announced it was changing its name to the…
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…
On Dec. 16, 2022, the U.S. Food and Drug Administration approved Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating…
On Dec. 9, 2022, the U.S. Food and Drug Administration (FDA) approved Genentech’s atezolizumab (Tecentriq) for adult and…
On Dec. 8, 2022, the Department of Veterans Affairs embarked on a study to determine the most effective…
On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment…
On Oct. 26, 2022, the Barbara Ann Karmanos Cancer Institute announced it had completed an over 50,000-square-foot expansion…
On Oct. 12, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced the Bezos family had committed $710.5 million…
On Sept. 21, 2022, the AACR released the 12th edition of its AACR Cancer Progress Report, an annual…
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
On Jul. 27, 2022, City of Hope announced that a 66-year-old man who was diagnosed with HIV in…
On Jun. 10, 2022, researchers from Case Western Reserve School of Medicine, Case Comprehensive Cancer Center, and The…
May 27, 2022, the National Cancer Institute (NCI) truncated the just-renewed five-year Cancer Center Support Grant held by…
On May 23, 2022, Jaguar Health announced the launch of Canine Cancer: Take C.H.A.R.G.E. (Canine Health And ReGistry…
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
On Apr. 1, 2022, the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) announced a…
On Mar. 21, 2022, in support of the Cancer Moonshot? goal of fostering data sharing in cancer research,…
On Mar. 21, 2022, in support of the Cancer Moonshot goal of fostering data sharing in cancer research,…
On Mar. 10, 2022, Howard Hughes Medical Institute announced that after more than two decades of effort researchers…
On Mar. 9, 2022, Harvard Medical School announced that an international research team had completed an atlas of…